Detailed analysis of treatment satisfaction with oral agents plus either basal insulin glargine or mealtime analogue insulin in patients with Type 2 diabetes – the APOLLO study. [Diabetes : Treatment Satisfaction]
Diabetic Medicine 23 (Suppl 4) 360 P1009.
Treatment satisfaction in patients with Type 2 diabetes: basal insulin plus oral agents versus twice-daily premixed insulin alone – analyses by country. [Diabetes : Treatment Satisfaction]
Diabetic Medicine 23 (Suppl 4) 361 P1010.
Metric properties of the MacDQoL in French, German, Italian and American populations: an individualised QoL instrument specific to Macular Disease (MD). [Macular Disease : Quality of Life]
Value in Health 9 (6) A372-A373. View article here.
Comments on ‘Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims’ [Generic]
Feedback on the FDA’s February 2006 draft guidance on Patient Reported Outcome (PRO) measures from a developer of PRO measures [Generic : Quality of Life]
Extent of satisfaction with tablets and food-timing in sulphonylurea-treated diabetes. [Diabetes]
Diabetes mellitus [Diabetes]
Diabetes, Type 1. [Diabetes]
In G Fink (Ed) Encyclopedia of Stress, 2nd Edition Oxford: Academic Press, 792-796.
Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ. [Hypothyroidism : Quality of Life]
Quality of Life and Health Economic Assessments of Age-Related Macular Degeneration. [Macular Disease : Treatment Satisfaction]
Survey of Ophthalmology 52 (1) S20-S25. View article here.
© 2015 Health Psychology Research Ltd. Company no. 4803452
Website by NDP Studio